Supporting health-financing advocacy with evidence-driven strategies

In health, persistent and emergent challenges include leadership, governance and coordination challenges. They affect fragmentation of funding; adequacy of funding, at sector and sub-sector levels; priority setting, which influences cost effectiveness of expenditure; efficiency and equity of spend, availability, access and use of quality data for decision-making; and sustainability and predictability of funding into the future.

These require intervention at different levels, including through advocacy.

We apply a suite of diagnostic and analytical approaches in health financing assessment to determine the adequacy, efficiency, cost-effectiveness and equity of financing for different disease and programmatic areas to identify where the priority need to policy intervention is. The disease areas we typically examine are RMNCH, HIV/AIDS, TB, malaria, NCD and ‘other diseases’.

By layering for example analysis on cost-effectiveness, we can determine which area is comparatively least cost-effective; or which dimension of health financing performance offers most opportunity for improvement. These insights are then used to streamline advocacy and influencing strategy, to increase their coherence and avoid conflicting messaging.

This is a global project with current focus on Burkina Faso, Ethiopia, India, Kenya and Nigeria.